Biomedical Engineering Reference
In-Depth Information
3. Yki-Jarvinen H, Vogt C, Iozzo P, Pipek R, Daniels MC,
Virkamaki A, et al. (1997) UDP-N-acetylglucosamine trans-
ferase and glutamine: fructose 6-phosphate amidotransferase
activities in insulin-sensitive tissues. Diabetologia 40(1),
76-81.
4. Zachara NE, Hart GW. (2004) O-GlcNAc a sensor of cellular
state: the role of nucleocytoplasmic glycosylation in modulat-
ing cellular function in response to nutrition and stress.
Biochim. Biophys. Acta 1673(1,2), 13-28.
5. Fares F. (2006) The role of O-linked and N-linked oligosac-
charides on the structure-function of glycoprotein hormones:
development of agonists and antagonists. Biochim. Biophys.
Acta 1760(4), 560-567.
6. Matzuk MM, Hsueh AJ, Lapolt P, Tsafriri A, Keene JL, Boime
I. (1990) The biological role of the carboxyl-terminal exten-
sion of human chorionic gonadotropin [corrected] beta-
subunit. Endocrinology 126(1), 376-383.
7. Matzuk MM, Krieger M, Corless CL, Boime I. (1987) Effects
of preventing O-glycosylation on the secretion of human
chorionic gonadotropin in Chinese hamster ovary cells.
Proc. Natl. Acad. Sci. USA 84(18), 6354-6358.
8. Kalyan NK, Bahl OP. (1983) Role of carbohydrate in human
chorionic gonadotropin. Effect of deglycosylation on the sub-
unit interaction and on its in vitro and in vivo biological
properties. J. Biol. Chem. 258(1), 67-74.
9. Sowers JR, Pekary AE, Hershman JM, Kanter M, DiStefano
JJIII. (1979) Metabolism of exogenous human chorionic
gonadotrophin in men. J. Endocrinol. 80(1), 83-89.
10. Van Den Hamer CJ, Morell AG, Scheinberg IH, Hickman J,
Ashwell G. (1970) Physical and chemical studies on cerulo-
plasmin. IX. The role of galactosyl residues in the clearance of
ceruloplasmin from the circulation. J. Biol. Chem. 245(17),
4397-4402.
11. Wide L. (1986) The regulation of metabolic clearance rate of
human FSH in mice by variation of the molecular structure of
the hormone. Acta Endocrinol. 112(3), 336-344.
12. Morell AG, Gregoriadis G, Scheinberg IH, Hickman J,
Ashwell G. (1971) The role of sialic acid in determining
the survival of glycoproteins in the circulation. J. Biol.
Chem. 246(5), 1461-1467.
13. Briggs DW, Fisher JW, George WJ. (1974) Hepatic clearance
of intact and desialylated erythropoietin. Am. J. Physiol.
227(6), 1385-1388.
14. Ashwell G, Kawasaki T. (1978) A protein from mammalian
liver that specifically binds galactose-terminated glycopro-
teins. Meth. Enzymol. 50, 287-288.
15. Yik JHN, Saxena A, Weigel JA, Weigel PH. (2002) Non-
palmitoylated human asialoglycoprotein receptors recycle
constitutively but are defective in coated pit-mediated endo-
cytosis, dissociation, and delivery of ligand to lysosomes.
J. Biol. Chem. 277(43), 40844-40852.
16. Fares FA, Suganuma N, Nishimori K, LaPolt PS, Hsueh AJ,
Boime I. (1992) Design of a long-acting follitropin agonist by
fusing the C-terminal sequence of the chorionic gonadotropin
beta subunit to the follitropin beta subunit. Proc. Natl. Acad.
Sci. USA 89(10), 4304-4308.
17. LaPolt PS, Nishimori K, Fares FA, Perlas E, Boime I, Hsueh
AJ. (1992) Enhanced stimulation of follicle maturation and
ovulatory potential by long acting follicle-stimulating hor-
mone agonists with extended carboxyl-terminal peptides.
Endocrinology 131(6), 2514-2520.
18. Bouloux PM, Handelsman DJ, Jockenhovel F, Nieschlag E,
Rabinovici J, Frasa WL, et al. (2001) First human exposure to
FSH-CTP in hypogonadotrophic hypogonadal males. Hum.
Reprod. 16(8), 1592-1597.
19. Devroey P, Fauser BC, Platteau P, Beckers NG, Dhont M,
Mannaerts BM. (2004) Induction of multiple follicular
development by a single dose of long-acting recombinant
follicle-stimulating hormone (FSH-CTP, corifollitropin
alfa) for controlled ovarian stimulation before in vitro
fertilization. J. Clin. Endocrinol. Metab. 89(5), 2062-
2070.
20. Abyholm T, Andersen A, Balen A, Braat D, Devroey P,
D'Hooghe T, et al. (2008) A randomized dose-response trial
of a single injection of corifollitropin alfa to sustain multi-
follicular growth during controlled ovarian stimulation. Hum.
Reprod. 23(11), 2484-2492.
21. Joshi L, Murata Y, Wondisford FE, Szkudlinski MW,
Desai R, Weintraub BD. (1995) Recombinant thyrotropin
containing a beta-subunit chimera with the human chorionic
gonadotropin-beta carboxy-terminus is biologically active,
with a prolonged plasma half-life: role of carbohydrate in
bioactivity and metabolic clearance. Endocrinology 136(9),
3839-3848.
22. Fares FA, Yamabe S, Ben-Menahem D, Pixley M, Hsueh AJ,
Boime I. (1998) Conversion of thyrotropin heterodimer to
a biologically active single-chain. Endocrinology 139(5),
2459-2464.
23. Grossmann M, Wong R, Szkudlinski MW, Weintraub BD.
(1997) Human thyroid-stimulating hormone (hTSH) subunit
gene fusion produces hTSH with increased stability and
serum half-life and compensates for mutagenesis-induced
defects in subunit association. J. Biol. Chem. 272(34),
21312-21316.
24. Fares F, Ganem S, Hajouj T, Agai E. (2007) Development of a
long-acting erythropoietin by fusing the carboxyl-terminal
peptide of human chorionic gonadotropin beta-subunit to
the coding sequence of human erythropoietin. Endocrinology
148(10), 5081-5087.
25. Egrie JC, Browne JK. (2001) Development and characteriza-
tion of novel erythropoiesis stimulating protein (NESP). Br. J.
Cancer 84(Suppl. 1), 3-10.
26. Nissenson AR. (2001) Novel erythropoiesis stimulating pro-
tein for managing the anemia of chronic kidney disease. Am.
J. Kidney Dis. 38(6), 1390-1397.
27. Higuchi M, Oh-eda M, Kuboniwa H, Tomonoh K, Shimonaka
Y, Ochi N. (1992) Role of sugar chains in the expression of the
biological activity of human erythropoietin. J. Biol. Chem.
267(11), 7703-7709.
28. Raben MS. (1958) Treatment of a pituitary dwarf with
human growth hormone. J. Clin. Endocrinol. Metab. 18(8),
901-903.
Search WWH ::
Custom Search